Qu Biologics is a biopharmaceutical company located in Burnaby, BC, Canada.
Qu Biologics is developing Site Specific Immunomodulators (SSIs), novel immunotherapies that are designed to stimulate an innate immune response to reverse the chronic inflammation underlying many conditions such as Crohn’s disease and ulcerative colitis.
Results from Qu’s initial clinical trials in Crohn’s disease and ulcerative colitis are now available. Enrollment is now open for our current clinical trial in Crohn’s disease. Please email email@example.com for more information or to be added to our mailing list.
To send us an e-mail, please fill out the form below.
We appreciate your interest and will make every effort to reply to your message as soon as possible.